United States Esoteric Testing Market Value - By Type (Endocrinology Testing, Infectious Diseases Testing, Oncology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing) By Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Real-Time PCR, Flow Cytometry, Radioimmunoassay), By End User (Hospital-based Laboratories and Independent & Reference Laboratories), By Industry Analysis, Size, Share & Forecast, 2023 – 2032

MVI Statistics and Viewpoints: 

• United States Esoteric Testing Market size valued at USD 7.2 Billion in 2022.
• The market is projected to grow at a CAGR of over 6.8% from 2023 to 2032. 
• By the end of the forecast period, the market is expected to surpass more than USD 13.8 Billion.

Manufacturers and companies in the esoteric testing industry in the United States constantly adapt their strategies to meet the changing needs of healthcare providers and patients, while also remaining at the forefront of diagnostic innovation. 

To get more info about this report - 

Market Overview:

The esoteric testing market in the United States is a thriving segment of the country's healthcare industry that focuses on specialized and advanced diagnostic testing. Esoteric tests are typically performed in specialized laboratories with cutting-edge technology and methodologies. These tests are intended to provide valuable information about rare diseases, genetic disorders, infectious diseases, and other conditions that are difficult to diagnose using traditional testing methods.

In recent years, the market for esoteric testing in the United States has grown significantly. Several factors contribute to this, including advances in molecular biology, genetic sequencing technologies, and increased demand for personalized medicine. Furthermore, the rising prevalence of chronic diseases and the aging population have created a demand for more accurate and precise diagnostic tools, driving demand for esoteric testing even higher.

National reference laboratories, academic medical centers, and independent specialty laboratories are among the key players in the United States market. These organizations provide a wide range of esoteric tests, such as genetic testing, infectious disease testing, autoimmune testing, oncology testing, and neurology testing.

To get more info about this report - 

Drivers:

• Advancements in Technology: Rapid advances in laboratory technology have greatly expanded esoteric testing capabilities. Next-generation sequencing, mass spectrometry, and advanced imaging techniques have enabled the development of more precise and comprehensive esoteric tests. These technological advancements drive the expansion of testing capabilities, resulting in an increase in demand for specialized testing services.
   
• Rising Prevalence of Chronic Diseases: The rising prevalence of chronic diseases like cancer, cardiovascular disease, and neurological disorders has increased the demand for esoteric testing. These complex diseases frequently necessitate the use of specialized diagnostic tests in order to identify specific genetic mutations, biomarkers, or disease subtypes. Esoteric tests are critical in diagnosing and monitoring these conditions, as they provide valuable information for treatment planning and disease management.

Restraints:

• High Price: When compared to routine laboratory tests, esoteric testing procedures frequently involve advanced technologies, specialized equipment, and highly trained personnel, which can result in higher costs. The high cost of esoteric testing can make it inaccessible to patients and healthcare providers, especially in resource-limited settings. The affordability of esoteric tests, as well as the availability of reimbursement options, are critical factors in their utilization.

By Type Synopsys:  

To get more info about this report -                   

The United States Esoteric Testing Market is classified by type into endocrinology testing, infectious diseases testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. Among these segments, the infectious diseases testing accounted for the largest share of the United States market in 2022. The detection and diagnosis of infectious agents such as bacteria, viruses, fungi, and parasites is part of infectious disease testing. This section contains tests for common infections such as influenza, HIV, and hepatitis, as well as tests for emerging and re-emerging infectious diseases. Rapid and accurate diagnosis is critical for effective infectious disease treatment, prevention, and control.  

By Technology Synopsys:        

The United States esoteric testing market is classified technology into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, and real-time pcr, flow cytometry, radioimmunoassay, and other technologies. Chemiluminescence immunoassay is a technique used to detect and quantify specific molecules such as antibodies, antigens, hormones, and proteins. CLIA measures the analyte of interest by measuring the emission of light caused by a chemical reaction. It is widely used in specialized testing for endocrinology, infectious diseases, oncology, and autoimmune disorders, among other things. For efficient testing, CLIA provides high sensitivity, a wide dynamic range, and automated platforms. 

Key Development:

In September 2022, The innovative Veratox VIP assay to detect cashew is the second in Neogen's new Veratox VIP line of enhanced quantitative ELISA products.

Top Companies Includes In The United States Esoteric Testing Landscape:

• Opko Health Company
• Exact Science Corporation
• Nordic Laboratories
• Laboratory Corporation of America
• Mayo Medical Laboratories
• Myriad Genetics
• Avista Capital Partners (Miraca Holdings Inc)
• Fulgent Genetics Inc
• Invitae
• Quest Diagnostic
• Sonic Healthcare (American Esoteric Laboratories (AEL)
• Others

To get more info about this report - 

In-depth analysis of United States Esoteric Testing Market along with industry coverage and forecasting for the following segments:

Market Size, By Type

• Endocrinology Testing
• Infectious Diseases Testing
• Oncology Testing
• Genetic Testing
• Toxicology Testing
• Immunology Testing
• Neurology Testing
• Others

Market Size, By Technology

• Chemiluminescence Immunoassay
• Enzyme-Linked Immunosorbent Assay
• Mass Spectrometry
• Real-Time PCR
• Flow Cytometry
• Radioimmunoassay
• Other Technologies

Market Size, By End User

• Hospital-based Laboratories  
• Independent & Reference Laboratories